NIKA PHARMACEUTICALS, INC (NIKA) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

-$76.4K

Total Assets (FY2025)

$21.0K

Total Equity (FY2025)

-$297.6K

Cash Flows from Operating Activities (FY2025)

-$79.7K

Source: NIKA PHARMACEUTICALS, INC 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.